Top Markets
#1 Black Phoenix Black Phoenix +354.49%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +75.51%
#4 Gold Park Gold Park +60.95%
#5 OpenEden OpenEden +38.44%
#6 Acurast Acurast +38.34%
#7 BasedHype BasedHype +27.03%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.32%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Rankning i aktier #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Aktiekurs
$0.13607016
Senast synkroniserad: 2024-09-10
Marknadsvärde
$112.29K
Förändring (1 dag)
22.46%
Förändring (1 år)
0.00%
Land
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategori

Healthcare
Aktiekurshistorik för BiVictriX Therapeutics Plc (BVX)
Högsta slutkurs: $0.11 den 2024-09-01

Lägsta slutkurs: $0.30 den 2021-08-01
Aktiekurshistorik för BiVictriX Therapeutics Plc från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE